Pharma faces 30-day deadline under Trump’s pricing order
US President Donald Trump has signed an executive order aimed at reducing prescription drug prices by linking them to what…
All articles by Jenna Philpott
Jenna Philpott
Jenna Philpott is a news and features reporter for Pharmaceutical Technology. Jenna holds a BSc in Biochemistry and has interests in rare diseases, gene therapies, and oncology. Contact Jenna
-
-
Trump to sign order tying US drug prices to global rates
In a renewed push to overhaul pharmaceutical pricing in the US, President Donald Trump announced he will sign an executive…
-
Pliant cuts workforce by 45% following lung trial termination
Pliant Therapeutics will cut 45% of its workforce in a sweeping restructuring effort aimed at extending its cash runway, the…
-
Glycomine raises $115m to advance rare disease therapy into Phase IIb
Glycomine has raised $115m in Series C financing to advance its lead investigational therapy, GLM101, into a Phase IIb clinical…
-
Verve’s shares jump by more than 26% on Lilly-partnered gene therapy data
Verve Therapeutics saw its stock surge by more than 26% when markets opened today (14 April) after the company announced…
-
FDA to phase out animal testing with AI and lab-based models
The US Food and Drug Administration (FDA) has announced plans to begin replacing animal testing in drug development with “more…
-
EU president to meet pharma leaders as tariff threat looms
European Commission (EC) President Ursula von der Leyen is set to hold talks with senior pharmaceutical executives today (8 April),…
-
Vertex halts development of diabetes cell therapy after trial failure
Vertex Pharmaceuticals has discontinued the development of VX-264, a type 1 diabetes (T1D) cell therapy delivered via an implantable device,…
-
HHS announces major workforce cuts and reorganisation
The US Department of Health and Human Services (HHS) will cut 10,000 full-time employees and restructure its divisions as part…
-
GSK and UK researchers plan to study Shingrix and dementia risk reduction link
GSK is collaborating with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to investigate…
